Showing 81-90 of 2293 results for "".
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31137/Clinical Insights: Recent Advances in NeurologyRecent genetic studies continue to illuminate the complex interplay between genetics and multiple sclerosis (MS). A genome-wide association study published in the *New England Journal of Medicine* identified heritable risk factors for MS, specifically a
Men With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/men-with-multiple-sclerosis/31758/Men with MS comprise an unlikely minority with distinct challenges that may also intersect with other signifiers of special populations.Multiple Sclerosis in the Hispanic/Latinx Population
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-hispaniclatinx-population/31757/Hispanic/Latinx individuals with MS are a diverse group for whom genetic and environmental factors affect prevalence, disease course, and treatment that varies by region.Multiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.Optic Neuritis: Update on Diagnosis, Management, and Long-term Follow-up
https://practicalneurology.com/columns/practice-management/PN1009_02-php/30879/Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31110/Adrenal insufficiency remains a significant clinical concern, particularly in patients undergoing long-term glucocorticoid therapy for conditions such as multiple sclerosis (MS). A pertinent case involves a 54-year-old woman with a decade-long history of primary progressive MS, managed with monthly
Atypical Patients with Typical Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0209_02-php/30945/Shifting epidemiological trends suggest that common perceptions of the "typical" MS patient may no longer be accurate.Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrelizumab-and-the-next-phase-in-multiple-sclerosis-therapy/30505/Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.Relapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.Multiple Sclerosis: Expanding the Field Beyond Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-expanding-the-field-beyond-management/31972/This issue provides a tour through a seemingly ever-expanding universe of applicable data on MS.